B. Braun Vascular Systems presents the first Drug Eluting Balloon for PTCA, based on a polymer-free carrier matrix. This most innovative product is the result of our sustained research for new options and improvements in the field of coronary angioplasty. Clinically proven, it offers completely new procedural options to treat vascular stenoses since the drug elution does not require a stent platform.
B. Braun has delivered innovative healthcare products, services and educational programs that enhance the care and safety of patients and healthcare professionals in the fields of drug delivery, IV therapy, pain control, clinical nutrition, dialysis and vascular intervention.